key: cord-1033642-qie7l5oh
authors: Kim, Tai Young; Jeon, Sangeun; Jang, Youngho; Gotina, Lizaveta; Won, Joungha; Ju, Yeon Ha; Kim, Sunpil; Jang, Minwoo Wendy; Won, Woojin; Park, Mingu Gordon; Pae, Ae Nim; Han, Sunkyu; Kim, Seungtaek; Lee, C. Justin
title: Platycodin D prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection in vitro by hindering membrane fusion
date: 2020-12-23
journal: bioRxiv
DOI: 10.1101/2020.12.22.423909
sha: bde1cc546187dff9dd495111cfd998179908a321
doc_id: 1033642
cord_uid: qie7l5oh

An ongoing pandemic of coronavirus disease 2019 (COVID-19) is now the greatest threat to the global public health. Herbal medicines and their derived natural products have drawn much attention to treat COVID-19, but there has been no natural product showing inhibitory activity against SARS-CoV-2 infection with detailed mechanism. Here, we show that platycodin D (PD), a triterpenoid saponin abundant in Platycodon grandiflorum (PG), a dietary and medicinal herb commonly used in East Asia, effectively blocks the two main SARS-CoV-2 infection-routes via lysosome- and transmembrane protease, serine 2 (TMPRSS2)-driven entry. Mechanistically, PD prevents host-entry of SARS-CoV-2 by redistributing membrane cholesterol to prevent membrane fusion, which can be reinstated by treatment with a PD-encapsulating agent. Furthermore, the inhibitory effects of PD are recapitulated by a pharmacological inhibition or gene-silencing of NPC1, which is mutated in Niemann-Pick type C (NPC) patients displaying disrupted membrane cholesterol. Finally, readily available local foods or herbal medicines containing PG root show the similar inhibitory effects against SARS-CoV-2 infection. Our study proposes that PD is a potent natural product for preventing or treating COVID-19 and that a brief disruption of membrane cholesterol can be a novel therapeutic approach against SARS-CoV-2 infection.

PD, a triterpenoid saponin present in Platycodon grandifloras, has a specific inhibitory 98 activity against SARS-CoV-2 entry. 99 To test for an anti-SARS-CoV-2 activity, we first developed a SARS-CoV-2 100 pseudovirus (pSARS-CoV-2), which carried the full-length S protein of SARS-CoV-2 on the 101 HIV-based lentiviral particles and the luciferase gene as a reporter (Crawford et al., 2020) , to 102 mimic the S protein of the native SARS-CoV-2 virus and retain its ability to bind to the host 103 cell surface receptors for viral infection. We then examined whether PG and PD can prevent 104 pSARS-CoV-2-entry into H1299, a human lung cell line known to be susceptible to 105 coronavirus infection (Tay et al., 2012) . Luciferase activity assay after infection with pSARS- 106 CoV-2 revealed that virus-entry into H1299 required overexpression of ACE2 (ACE2 + ) 107 ( Figure S1 ). In ACE2 + , we found that 1-hour treatment with PG and PD effectively reduced To determine which one of the two entry pathways is the target of PD, we prepared 126 additional cell lines, H1299 and HEK293T, overexpressing both ACE2 and TMPRSS2 127 (ACE2/TMPRSS2 + ) and compared the inhibitory effect of various drugs with ACE2 + . We 128 found that E64d and chloroquine, inhibitors of lysosomal cathepsins, effectively blocked 129 pSARS-CoV-2-entry only in ACE2 + , but not in ACE2/TMPRSS2 + , whereas camostat and 130 nafamostat, inhibitors of TMPRSS2, effectively blocked pSARS-CoV-2-entry in 131 ACE2/TMPRSS2 + , but not in ACE2 + (Figure 2A, B) . In contrast, 5 mM PD completely 132 inhibited pSARS-CoV-2 entry in both ACE2/TMPRSS2 + and ACE2 + . (Figure 2A, B) . The 133 actual potency of PD for inhibition of pSARS-CoV-2-entry in terms of IC50's in 134 ACE2/TMPRSS2 + was determined to be 0.72 mM (Figure 2C) , which was almost identical to 135 that in ACE2 + ( Figure 1D) . These results suggest that PD targets any one of the events that is 136 common to both entry pathways. 137 Yonggaksan (YGS, Figure 2D ), whose main ingredient is an extract powder from the 138 PG root, has been available as an over-the-counter medicine and used for treatment of phlegm, 139 cough, and sore throat for more than 50 years in Korea and 200 years in Japan. Thus, we 140 examined whether YGS can be a potential nonprescription medicine to block SARS-CoV-2 141 infection. We found that a dilute solution of YGS effectively inhibited pSARS-CoV-2-entry 142 into both ACE2 + and ACE2/TMPRSS2 + in a dose-dependent manner with similar IC50's of 143 3.17 mg/ml in ACE2 + ( Figure 2E ) and 3.72 mg/ml in ACE2/TMPRSS2 + (Figure 2F ), 144 suggesting a therapeutic potential of YGS for SARS-CoV-2. Another main ingredient of YGS 145 is an extract powder from the liquorice roots, whose active compound is glycyrrhizin with an 146 inhibitory action in replication and penetration of SARS-CoV (Cinatl et al., 2003 ) and a 147 suggested therapeutic potential for COVID-19 ). Thus, we tested the effect of 148 glycyrrhizin as well as isoliquiritigenin, other major components of liquorice roots, on the entry 149 of pSARS-CoV-2. We found that both compounds exhibited no significant inhibitory activity 150 against pSAR-CoV-2-entry in both ACE2 + and ACE2/TMPRSS2 + (Figure 2G, H) . Moreover, 151 mixing the two compounds with 1 mM PD did not either enhance or reduce pSARS-CoV-2- In Korean culture, the root of PG is often served as a side dish in daily meals. For 164 example, PG syrup (PGS) has been considered as a folk remedy for relieving several symptoms 165 of respiratory diseases. PGS ( Figure 2M ) is prepared by chopping PG roots ( Figure 1A ) into 166 small pieces and marinating them in sugar or honey for several months to be mixed with warm 167 water and served as a drink. To test if PGS also shows inhibitory effect on pSARS-CoV-2-168 entry, we treated ACE2 + and ACE2/TMPRSS2 + with serial three-fold dilutions of PGS stock 169 solution containing 15 mg/ml of the PG root for 1 h, before infection of pSARS-CoV-2. We 170 found that PGS effectively inhibited pSARS-CoV-2-entry with similar IC50's of 2.91 mg/ml 171 ( Figure 2N ) in ACE2 + and 3.69 mg/ml in ACE2/TMPRSS2 + ( Figure 2O) . Moreover, HPLC 172 analysis demonstrated that PD is the main active compound in PG root with inhibitory activity 173 against pSARS-CoV-2-entry ( Figure S2, S3) . These results suggest that even dietary foods 174 containing PG roots might also have beneficial effects on COVID-19 patients. 

To delineate the detailed molecular and cellular mechanism of PD action, we explored 178 two possible events that are common to both entry pathways; 1) the initial binding of S protein 179 to ACE2 at the plasma membrane and 2) the fusion of viral membrane onto host-cell membrane To test if PD blocks SARS-CoV-2-entry by disrupting the membrane cholesterol, we 220 utilized methyl β-cyclodextrin (MβCD), whose doughnut-shaped structure makes it a natural 221 complexing agent that can encapsulate cholesterol and other large molecules such as hormones, 222 vitamins and natural hydrophobic macro-compounds (Dai et al., 2017) . It has been 223 demonstrated that when cells are exposed to high concentration of MβCD (5-10 mM) for more 

As a final measure, we evaluated the antiviral activity of PD on the authentic SARS- CoV-2 infection, which blocks both of the entry pathways with much higher potency than the 329 existing drug candidates such as chloroquine, camostat, and nafamostat.

One of the highlights of our study is that PD alters the distribution of membrane (Fig. 1d, l) and in lipoprotein-free culture condition. PD was placed using a rigid alignment, maximum common structure molecular overlay tool.

To account for the increase of the macrocycle size, as well as remove molecular strain and 701 atomic bumps and relax the binding complex structures, a restrained energy minimization 702 algorithm was applied using the OPLS3 force field and heavy atom RMSD restriction of 2 Å.

The obtained ligand binding poses were scored in place by the Glide SP (standard precision) 704 dock score and afterwards the relative ligand binding affinity was estimated by the Prime MM- Cl -) without performing system equilibration.

726 Figure 1 

For the brain acute slicing, 5 weeks C57BL/6J mice were anesthetized with isoflurane and 729 decapitated. The The 300 μm transverse slice of hippocampus were prepared in ice-cooling 730 NMDG-based cutting solutions (93 mM NMDG; 2.5 mM KCl; 1.2 mM NaH2PO4; 30 mM 731 NaHCO3

Sodium pyruvate, 10 mM MgCl2, 0.5 mM CaCl2

Ltd) and recovered 15 minutes at 32℃ in the same 734 solution. Slices were re-recovered in oxygenated ACFS solution (126 mM NaCl; 24 mM 735 NaHCO3; 2.5 mM KCl; 1 mM NaH2PO4; 2 mM MgCl2; 10 mM Glucose). Spontaneous IPSC 736 was recorded under oxygenated ACFS solution by whole-cell voltage-clamp. Recording 737 electrodes (6-8 MΩ) fabricated from standard-wall borosilicate glass

USA) were filled with an CsCl-based internal solution (135 mM CsCl; 4 mM 739 NaCl; 0.5 mM CaCl2; 10 mM HEPES; 5 mM EGTA, 0.5 mM Na2-GTP

For the acute PD treatment and sIPSC recording, 10uM PD containing-ACSF 741 were applicated after setup the baseline. For the long-term PD treatment and sIPSC recording, 742 slices were incubated in PD containing-ACSF (0, 0.3, 1, 3, 10, 30 μM, respectively) at least c 743 one hour and whole-cell voltage-clamp recording in the same solutions. sIPSC was recorded at 744 least 5 minutes. For sIPSC frequency and amplitude analyzing

Data in this study were representative of two or three independent experiments with triplicate 750 samples and presented as the mean ± SEM. Statistical analysis was performed using student's 751 t-test or one-way ANOVA followed by Tukey's post hoc test

001; ****P < 0.0001; NS, 753 not significant)

Distinct conformational states of SARS-CoV-2 spike protein

Niemann-Pick C1 disease gene: 761 homology to mediators of cholesterol homeostasis

Inhibitory effect of Platycodi Radix 763 on ovalbumin-induced airway inflammation in a murine model of asthma

Crystal structure of the inclusion 766 complex of cholesterol in beta-cyclodextrin and molecular dynamics studies

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated 770 coronavirus

Protocol and Reagents for Pseudotyping 773

Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

775 and Zheng

Pick C1-deficient cells through activation of AMPK

Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Chloroquine does not 783 inhibit infection of human lung cells with SARS-CoV-2

SARS-CoV-2 Reverse Genetics Reveals 786 a Variable Infection Gradient in the Respiratory Tract

Current Prevention of 788 COVID-19: Natural Products and Herbal Medicine

Ginseng, the natural effectual antiviral: Protective effects 790 of Korean Red Ginseng against viral infection

Rapid effects of Kikyo-to on sore 792 throat pain associated with acute upper respiratory tract infection

Why does Japan have so few cases of COVID-19?

In 797 silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using 798 molecular docking

Phylogenetic Analysis and Structural Perspectives of RNA-801

Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products

Triterpenoid Saponins Isolated from Platycodon grandiflorum Inhibit Hepatitis C Virus 805

Comparative analysis of antiviral efficacy of 807 FDA-approved drugs against SARS-CoV-2 in human lung cells

Angiotensin-converting enzyme 810 2 is a functional receptor for the SARS coronavirus

Cathepsin L-selective inhibitors: A potentially 812 promising treatment for COVID-19 patients

Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal 815 cholesterol export and Ebola infection

Pharmacological perspective: glycyrrhizin may be an 817 efficacious therapeutic agent for COVID-19

A SARS-like cluster of 820 circulating bat coronaviruses shows potential for human emergence

Platycodon grandiflorum and Their Health Benefits

No benefit of 825 hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of 826

Randomized Controlled Trials

Antiviral activity of 828 cationic amphiphilic drugs

Geranium and Lemon Essential Oils and Their Active 831

Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike 832 Receptor-Binding Domain

Platycodin D and D3 increase 834 airway mucin release in vivo and in vitro in rats and hamsters

Genetic evidence for nonredundant functional 837 cooperativity between NPC1 and NPC2 in lipid transport

Historical Medical Value of Donguibogam

Pseudopolymorphism in 842 tetradeca-2,6-O-methyl-beta-cyclodextrin: the crystal structures for two new hydrates-843 conformational variability in the alkylated beta-cyclodextrin molecule

SARS-CoV-2 entry factors are highly 847 expressed in nasal epithelial cells together with innate immune genes

The 849 cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection

Characterization of cellular 852 furin content as a potential factor determining the susceptibility of cultured human and animal 853 cells to coronavirus infectious bronchitis virus infection

Silico 855 Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-856

Remdesivir and chloroquine effectively inhibit the recently emerged novel 859 coronavirus (2019-nCoV) in vitro

Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and 862 other coronaviruses by depleting membrane cholesterol

IFITM proteins inhibit entry driven by the 864

MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms

The Anticoagulant

Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay 869 System and Viral Infection In Vitro in a Cell-Type-Dependent Manner

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by 872 blocking membrane fusion

Platycodin D Suppresses Type 2 Porcine Reproductive and Respiratory 875

Syndrome Virus In Primary and Established Cell Lines

Platycodin D Attenuates Airway 877 Inflammation in a Mouse Model of Allergic Asthma by Regulation NF-kappaB Pathway

Cholesterol-880 lowering effect of platycodin D in hypercholesterolemic ICR mice

Use of cyclodextrins to manipulate plasma membrane 883 cholesterol content: evidence, misconceptions and control strategies

SARS-CoV-2 Receptor ACE2 Is an

Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell 888 Subsets across Tissues

25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor